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Human cytomegalovirus (HCMV) is a major cause of viral disease in the young and 
the immune-suppressed. At sites of infection, HCMV recruits the neutrophil, a cell with 
a key role in orchestrating the initial immune response. Herein, we report a profound 
survival response in human neutrophils exposed to the clinical HCMV isolate Merlin, but 
not evident with the attenuated strain AD169, through suppression of apoptosis. The 
initial survival event, which is independent of viral gene expression and involves activation 
of the ERK/MAPK and NF-κB pathways, is augmented by HCMV-stimulated release 
of a secretory cytokine profile that further prolongs neutrophil lifespan. As aberrant 
neutrophil survival contributes to tissue damage, we predict that this may be relevant to 
the immune pathology of HCMV, and the presence of this effect in clinical HCMV strains 
and its absence in attenuated strains implies a beneficial effect to the virus in patho-
genesis and/or dissemination. In addition, we show that HCMV-exposed neutrophils 
release factors that enhance monocyte recruitment and drive monocyte differentiation 
to a HCMV-permissive phenotype in an IL-6-dependent manner, thus providing an ideal 
vehicle for viral dissemination. This study increases understanding of HCMV–neutrophil 
interactions, highlighting the potential role of neutrophil recruitment as a virulence mech-
anism to promote HCMV pathology in the host and influence the dissemination of HCMV 
infection. Targeting these mechanisms may lead to new antiviral strategies aimed at 
limiting host damage and inhibiting viral spread.
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inTrODUcTiOn
Neutrophils are the most abundant circulating leukocytes and represent the first line of innate 
immunity against infection. They are terminally differentiated polymorphonuclear granulocytes 
with a short half-life in the circulation and a propensity to undergoing rapid constitutive apoptosis 
when aged in vitro. This latter response, which is observed during inflammatory resolution in vivo, 
triggers a highly efficient process of macrophage-mediated engulfment or efferocytosis, which 
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prevents these cells from releasing their cytotoxic content (1). 
Apoptosis is a highly adaptable cellular process influenced by a 
number of external factors including adhesion (2), hypoxia (3), 
inflammatory cytokines (4), and microbial agents (5), which 
mostly act to delay apoptosis and prolong neutrophil survival. 
While the prolongation of neutrophil lifespan may be critical for 
efficient handling of bacteria and certain fungi (6), inappropriate 
neutrophil longevity at sites of inflammation is thought to be 
pathogenic and contribute to inflammation-mediated damage 
(7). Conversely, an enhanced susceptibility to apoptosis may 
contribute to the likelihood of recurrent infections (8, 9), imply-
ing that neutrophil apoptosis needs to be tightly regulated to 
ensure efficient pathogen clearance yet timely and safe immune 
cell clearance.
Certain bacteria have developed mechanisms to manipulate 
the apoptotic machinery of the neutrophil, either delaying 
apoptosis to allow time for intracellular replication (10, 11) and/
or using the cell as a “Trojan horse” to facilitate dissemination 
through the transfer of viable microorganisms within apoptotic 
neutrophils to efferocytosing macrophages, thus promoting sub-
sequent spread (12, 13).
Several lines of evidence suggest an equally important role 
for neutrophils during viral infection. Hence, enhanced defensin 
expression has been shown to aid control of viruses such as HIV, 
adenovirus, and herpes simplex virus (14–16). Furthermore, 
recent evidence suggests that neutrophils play a key role in 
controlling murine CMV replication at secondary sites of infec-
tion (17). Neutrophils also attract and stimulate other immune 
cells both through direct interaction with cells such as dendritic 
cells (DCs) (18) and through the release of pro-inflammatory 
chemokines and cytokines (19); this illustrates their potential to 
orchestrate an adaptive immune response to viral infection.
Human cytomegalovirus (HCMV) is an opportunistic patho-
gen, which causes severe morbidity in neonates and the immune 
compromised (20–22). Disease can result from primary infection 
or reactivation from previously established latent infection and, 
due to the extensive cellular tropism of the virus, can manifest in 
a diverse range of tissues (23). Understanding the onset and pro-
gression of HCMV pathogenesis is an important area of ongoing 
research. However, the precise nature of any interaction between 
HCMV and neutrophils still remains unclear. Neutrophils from 
healthy latent seropositive patients are HCMV genome negative 
(24), and although the HCMV antigen pp65 has been detected 
in the neutrophils of viremic patients (25, 26), this does not 
reflect a full viral replicative life cycle, as demonstrated by the 
lack of detectable immediate early (IE) or late viral mRNA (27). 
Due to the highly phagocytic nature of neutrophils, it has been 
suggested that intracellular pp65 may in fact represent ingestion 
of viral material rather than primary lytic infection (27), and the 
presence of viral DNA in the neutrophil cytoplasm might also be 
consistent with its presence in phagosomes (28).
Although certain HCMV nucleic acids have been detected in 
the neutrophils of viremic patients (29, 30), neutrophils appear 
unable to produce viral transcripts following direct infection 
in  vitro, and experimental studies have relied on co-culture of 
neutrophils with infected endothelial cells (31, 32) or human 
embryonic lung fibroblasts (33) before any evidence of an abortive 
infection in neutrophils (31). The short lifespan of neutrophils 
would also argue against them being a major site of productive 
infection especially given the protracted life cycle of HCMV; 
despite this, HCMV carriage in neutrophils can occur in immune-
compromised patients and may play a role in a number of CMV 
disease states including retinitis in late-stage AIDS patients 
(34, 35). HCMV has also been reported to encode the chemokine 
mimic viral CXC-chemokine-1 (vCXC-1), a potent chemoat-
tractant for neutrophils (36, 37), and it has been hypothesized 
that this may support rapid viral dissemination from the site of 
infection—a characteristic of HCMV.
In this study, we have further investigated the interaction 
of HCMV with neutrophils. We show that, independently of 
a co-culture system, cell-free HCMV has a profound effect on 
neutrophil survival and cytokine expression, independent of viral 
gene expression but dependent on intracellular signaling involv-
ing ERK1/2 and NF-κB, and MCL-1 stabilization. This effect was 
observed to be viral strain dependent, with the AD169 HCMV 
strain, which displays a large deletion in the ULb′ genome region, 
unable to promote neutrophil survival.
Furthermore, the HCMV-stimulated neutrophil secretome 
was found to have significant paracrine effects on both neutro-
phils and monocytes. The ensuing neutrophil inflammatory cyto-
kine profile further promotes neutrophil survival, enhances the 
chemotactic response of autologous monocytes, and promotes 
monocyte differentiation to a state permissive for HCMV infec-
tion. These findings support the hypothesis that the neutrophil–
HCMV interaction aids efficient dissemination of the virus, by 
generating a favorable environment to modulate the phenotype 
of infiltrating monocytes—the primary vehicle for viral dissemi-
nation and persistence in the infected host (38).
MaTerials anD MeThODs
ethics statement
The Cambridge Local Research Ethics Committee approved all 
experiments utilizing primary human cells. The collection of 
venous blood samples from anonymous donors was performed 
in accordance with established guidelines for the handling 
and processing of tissue as defined by the Cambridge Local 
Research Ethics Committee, including informed written consent 
(06/Q0108/281).
Virus culture and reagents
The viral isolates TB40/e, Merlin, and AD169 were purified 
from the supernatants of infected human foreskin fibroblasts 
(HFFs) using sorbitol gradients as previously described (39) 
and stored in Iscove’s Modified Dulbecco’s Medium (IMDM) at 
−70°C. Briefly, viral strains were seeded onto HFF monolayers 
and cultured in DMEM containing 10% fetal calf serum and 1% 
penicillin/streptomycin for 10–14  days until 100% cytopathic 
effect was observed. HFF supernatants containing virus were 
collected every 48 h and stored at −70°C. Virions were pelleted 
by centrifugation of supernatants (12,000  rpm, 2  h, 4°C) and 
then loaded onto six sorbitol gradients (20–70%) before further 
density centrifugation (20,000  rpm, 1  h, 4°C). Purified virus 
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particles were collected from the 50 and 60% gradients, washed 
in PBS, and resuspended in IMDM for storage at −70°C as viral 
inoculum. The viral inoculum was titred by sowing onto a known 
quantity of HFFs and staining for IE antigen after 24 h to calculate 
the concentration in plaque-forming units per milliliter, and the 
volume of viral inoculum calculated to give a standardized MOI 
was added to neutrophil wells for experiments.
AD169 was obtained from the ATCC and TB40/e from 
Professor Christian Sinzger (University of Ulm, Germany). WT 
and mutant Merlin strains were obtained from Dr. Peter Tomasec 
(University of Cardiff, UK). The Merlin strain deletion mutants 
were generated by recombineering of the bacterial artificial chro-
mosome of the original Merlin strain (GenBank GU179001.1) as 
previously described (40), and the genomes were confirmed by 
Illumina sequencing.
For inactivation of the virus, purified viral stocks were UV 
irradiated in a class II MSC for 40 min, with the activation status 
confirmed by inoculation of fresh HFFs and examination for 
cytopathic effects at 7–14 days postinfection.
leukocyte Purification
Primary human blood neutrophils were obtained from healthy 
adult donors or CMV pneumonitis patients and purified by dex-
tran sedimentation and discontinuous plasma-Percoll™ gradi-
ents as previously detailed (41). For protocols requiring ultrapure 
neutrophils, cells were isolated by semiautomated negative 
selection using a RoboSep® (StemCell Technologies, Vancouver, 
BC, Canada), according to the manufacturer’s instructions, with 
neutrophil purity >98% as determined by light microscopy of 
cytospins.
CD14+ isolation of human monocytes was performed using 
a CD14+ cell direct isolation kit (Miltenyi Biotec, Auburn, CA, 
USA) and magnet-activated cell sorting. Primary CD14+ cells 
were cultured in X-vivo-15 media (Cambrex, Walkersville, MD, 
USA) and differentiated into DCs by the addition of interleukin-4 
(100 ng/ml) and GM-CSF (100 ng/ml) (Peprotech, Rocky Hill, 
NJ, USA).
leukocyte culture and infection
Purified neutrophils were suspended at a final cell concentration 
of 5 × 106/ml in IMDM (Thermo Fisher Scientific, Loughborough, 
UK) supplemented with 10% autologous serum and 50  U/ml 
streptomycin and penicillin (Thermo Fisher Scientific, Loughbor-
ough, UK). Cells were plated using cell-saver pipette tips into 
round-bottom ultra-low attachment 96-well Flexiwell plates 
(Becton Dickinson, Oxford, UK) and purified cell-free viral 
inoculum, at a volume calculated to give a standardized MOI, 
was added to the wells. For experiments involving virion-free 
inoculum, the inoculum was ultracentrifuged (130,000  g, 2  h, 
4°C) in a Beckman Coulter Optima ultracentrifuge (Beckman 
Coulter, Buckinghamshire, UK), to pellet and remove all infec-
tious virions prior to adding to wells. For experiments involving 
transferrable survival or supernatant effects, purified neutrophils 
from a second healthy donor, or autologous monocytes, were 
resuspended in the warmed supernatant harvested from infected 
neutrophils at 18 h, at a concentration of 5 × 106 cells/ml before 
plating as described.
For monocyte infections, 5 × 106 monocytes were incubated 
for 30 min with HCMV and cultured overnight in fresh X-vivo-15 
supplemented with 2 mM l-glutamine. For experiments involv-
ing inhibitors, compounds or diluent control media were added 
to wells prior to HCMV addition and were present for the dura-
tion of culture.
inhibitors, agonists, and antibodies
The following agonists were used: Pam3CSK4 (TLR1/2, 0.01–
1000 ng/ml, Invivogen, San Diego, CA, USA), ultrapure LPS-EB 
(TLR4, 10–1000  ng/ml Invivogen, San Diego, CA, USA). The 
following inhibitors were used: U0126 (ERK1/2, 1 µM, 60 min 
pre-incubation), PD98059 (MEK1/2, 50 µM), LY294002 (PI3K, 
10  µM, 60  min pre-incubation), wortmannin (PI3K, 100  nM), 
BAY-11-7085 (NF-κB, 3 µM, 60 min pre-incubation), IKK inhibi-
tor VII (IKK, 10 µM), SB203580 (p38, 10 µM), SP600125 (JNK, 
5  µM), cytochalasin D (endocytosis, 10  µg/ml; Sigma, Poole, 
UK), latrunculin A (endocytosis, 10  µM; Sigma, Poole, UK), 
PAb hTLR2 (TLR2, 10 µg/ml; Invivogen, San Diego, CA, USA), 
CLI-095 (TLR4, 1 µg/ml, 60 min pre-incubation; Invivogen, San 
Diego, CA, USA), 324841 (FGF-R1/PDGF-R1/EGF-R, 1  µM, 
60 min pre-incubation), actinonin (CD13, 100 nM; Sigma, Poole, 
UK), and anti-CD13 clone WM15 (CD13, 8 µg/ml) (all Merck 
Millipore, Nottingham, UK, unless stated). Inhibitors were added 
30 min prior to infection unless stated. Wortmannin (100 nM) 
was added again at 4, 8, and 12 h incubation due to its instability 
in aqueous solution.
immunofluorescence
For immunofluorescent detection of viral IE gene expression, 
cells were fixed in 70% ethanol (30 min, −20°C) and then incu-
bated with an anti-IE antibody (1:1,000; Millipore, Darmstadt, 
Germany) followed by Alexafluor 594 nm-conjugated goat anti-
mouse antibody (1:1,000; Millipore, Darmstadt, Germany), both 
for 1  h at room temperature (RT). Nuclei were counterstained 
with Hoechst (1:1,000; Sigma, Poole, UK).
Western Blotting
Neutrophils were harvested and analyzed by Western blot 
using polyclonal antibodies to AKT, phospho-AKT, phospho-
ERK1/2, IκB, Mcl-1, Bax, and β-actin (New England Biolabs, 
Hertfordshire, UK). Detection was performed with the appro-
priate peroxidase-conjugated secondary antibodies (1:2,000) 
for 1  h. Chemiluminescence (ECL-plus-kit GE Life Sciences, 
Buckinghamshire, UK) and exposure to X-ray film (XOMAT-AR; 
GE life sciences, Buckinghamshire, UK) were used to detect 
banding.
nucleic acid isolation, reverse 
Transcription, amplification,  
and gel electrophoresis
RNA (cDNA) and DNA were amplified using the gene-specific 
primers GAPDH: 5′-GAG TCA ACG GAT TTG GTC GT and 
5′-TTG ATT TTG GAGGGA TTC TCG, IE: 5′-CAT CCA CAT 
CTC CCG CTT AT and 5′-CAC GAC GTT CCT GCA GAC 
TAT G, in PCR 2x Mastermix (Promega, Madison, WI, USA). 
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The following cycling conditions were applied: 95°C (5  min), 
then 20–40 cycles of 94°C (40 s), 55°C (40 s), and 72°C (60 s) and 
a final extension at 72°C for 10 min.
qPcr analysis
Total RNA was isolated from neutrophils using TRI-reagent (Sigma, 
Poole, UK) followed by clean-up and DNase digest using RNeasy 
column kits (Qiagen). First-strand synthesis was performed with 
1  µg of RNA (high-capacity cDNA kit, Applied Biosystems). 
Relative gene expression was determined by qPCR (ABI) and 
amplified in Sybr-green master mix (Applied Biosystems) with 
relevant primers from Qiagen. Gene expression levels were rela-
tive to β2 microglobulin using the 2−CT method (42).
Detection of neutrophil apoptosis by 
Morphology, electron Microscopy (eM), 
Flow cytometry, and caspase-3 activity
Neutrophils were harvested at the time points indicated, cytocen-
trifuged (300 rpm, 3 min, RT) in a Shandon cytospin 3 (Shandon, 
UK), fixed in methanol, stained with May-Grünwald-Giemsa 
(Merck Millipore, Nottingham, UK), and examined under oil 
immersion (×100 objective) light microscopy, with the observer 
blinded to the experimental condition. Apoptotic neutrophils 
were defined as those with darkly stained pyknotic nuclei (300 
cells counted/slide, 3 slides per condition and time point) (43).
For EM analysis (CM100 transmission electron microscope; 
Philips, UK), infected neutrophils were harvested by centrifuga-
tion, fixed in glutaraldehyde and osmium tetroxide, dehydrated 
in ethanol, and embedded in Spurr’s resin for sectioning.
Flow cytometric analysis was performed by incubating cells 
with 5 µl annexin V-FITC and 5 µl propidium iodide for 20 min at 
4°C (both BD Biosciences, Oxfordshire, UK). Cells were analyzed 
by flow cytometry on a BD Accuri™ cytometer (BD Biosciences, 
Oxfordshire, UK) with 10,000 cells analyzed per condition and 
data were handled using FlowJo V8.7.1 software (Tree Star, 
Ashland, OR, USA).
Caspase-3 activity was ascertained on neutrophils incubated 
with and without HCMV for 18 h by colorimetric caspase-3 assay 
(Abcam, Cambridgeshire, UK). Neutrophils were cultured for the 
time period indicated, pelleted, washed in PBS, and resuspended 
in lysis buffer according to the manufacturer’s instruction, for 
plate reading to detect cleaved colorimetric caspase-3-substrate 
at 405 nm.
secretome analysis
Mock and HCMV condition neutrophil supernatants were har-
vested following 20 h culture and stored at −80°C until use. Some 
were ultracentrifuged (130,000 g, 2 h, 4°C) in a Beckman Coulter 
Optima ultracentrifuge (Beckman Coulter, Buckinghamshire, UK) 
prior to storage, to pellet and remove all remaining infectious 
virions. Depletion of virions from ultracentrifuged supernatants 
was confirmed by sowing the supernatants onto confluent HFFs 
and staining for IE antigen after 24 h. The presence of inflam-
matory mediators in the supernatant of mock and HCMV-
treated neutrophils was determined by multispot array using 
the MesoScale Discovery Platform (Meso Scale Diagnostics, 
Rockville, MA, USA), with resultant blots quantified by electro-
chemical luminescence detection.
To assess IL-6 and IL-8 in supernatants, in-house ELISAs 
were used (44). Briefly, a 96-well microplate was incubated 
with mouse monoclonal anti-human IL-6 or anti-human IL-8 
antibody (2  µg/ml) for 2  h at RT. After washing, wells were 
blocked using 5% fetal calf serum in PBS-T for 1 h at RT, washed 
again, and incubated overnight (4°C) with samples and rhIL-6 
or rhIL-8 standards. Detection of IL-6 and IL-8 was performed 
using a biotinylated anti-human IL-6 or anti-human IL-8 detec-
tion antibody and ExtrAvidin-AP (Sigma, Poole, UK), followed 
by p-nitrophenyl phosphate (1 mg/ml in diethanolamine). Plates 
were read using a Biorad Micro 680 microplate reader at 450 nm.
IL-8 and IL-6 neutralization in neutrophil supernatants was 
performed using human-IL-8 mAb (1 µg/ml; R&D systems, UK) 
and human-IL-6 mAb (1 µg/ml; R&D Systems, UK). Antibodies 
were added to supernatants 60  min prior to the addition of 
washed protein A micro-beads (Sigma, Poole, UK) for a further 
120 min (4°C). The beads were removed by placing vessels in a 
magnet and IL-6 and IL-8 depletion confirmed by ELISA.
cell Migration and Phenotyping assays
To assess cell migration to supernatants, transwell plates (5 µm 
pores, 30 µl well volume) (Neuroprobe, USA) were used. Monocytes 
were labeled using Calcein (BD Biosciences, Oxfordshire, 
UK). 2 × 104 labeled cells in 20 µl of RPMI 1640 per well were 
transferred to the transwell plate and incubated at 37°C for 2 h 
with supernatants from mock or HCMV-infected neutrophils. 
Migrated cells were counted using an inverted UV microscope 
(sum of five fields of view from each well, assays performed in 
triplicate for each donor).
Monocyte immunophenotyping analysis was performed on 
purified CD14+ cells after 3  days culture in X-vivo-15 media, 
neutrophil conditioned media, or Merlin-infected neutrophil 
conditioned media, using antibodies directed against HLA-ABC 
(MHC class I) and HLA-DR (MHC class II) with the appropriate 
fluorochrome-conjugated isotype controls (BD Life Sciences, 
Frankin Lakes, NJ, USA). 105 cells were pelleted (400 g for 5 min), 
resuspended and incubated with the target antibody or control 
for 20 min, washed once, and resuspended in 500 µl PBS before 
analyzing by flow cytometry (BD FACScalibur). Data were han-
dled using WinMDI2.9 software.
A mixed leukocyte reaction was performed using 5  ×  104 
CD14+ monocytes and incubated for 3  days with X-vivo-15 
media or supernatants from mock- or HCMV-infected neutro-
phils. Media was then replaced with fresh media (RPMI-10) sup-
plemented with IL-2, containing 105 purified allogeneic T cells 
purified from peripheral blood mononuclear cells by negative 
selection using the RosetteSep Procedure (StemCell Technologies, 
Grenoble, France). T  cell proliferation was quantified by cell 
counting after 6 days of co-culture.
statistical analysis
Data were plotted as mean ±  SEM and analyzed using Prism 
V6 (GraphPad) software. A paired or unpaired t-test was used 
to evaluate differences in experimental results, or a one-way 
analysis of variance with post hoc significance testing by Dunnet’s 
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test in experiments with >2 variables. Statistical significance 
was defined as p < 0.05.
resUlTs
hcMV Promotes neutrophil survival 
independently of Viral gene expression
Neutrophil co-culture with HCMV-infected fibroblasts has previ-
ously been shown to upregulate neutrophil effector function and 
survival (32). Since clinical strains of HCMV encode chemokines, 
which promote neutrophil recruitment (17, 45) but only exhibit 
limited replication in neutrophils, we investigated the nature of 
the neutrophil interaction with cell-free HCMV, specifically to 
identify any potential benefit to the virus. We used the Merlin 
strain that has become the genetic reference for clinical isolates 
of HCMV (40). Exposure of neutrophils to Merlin protected 
them from undergoing constitutive time-dependent apoptosis, 
as judged by morphological analysis under light microscopy 
(Figure  1A), which revealed a reduction in apoptotic cells 
containing darkly stained pyknotic nuclei at 20 h (Figure 1B). 
This was supported by flow cytometry using the apoptosis marker 
annexin V, which binds to externalized phosphatidylserine on the 
membrane of apoptotic cells. Co-staining with propidium iodide 
excluded necrotic cells (Figures  1C,D). EM visually separated 
the ruffled plasma membrane of viable HCMV-treated cells from 
the smooth featureless surface of apoptotic cells (Figure  1E). 
Classically, neutrophil apoptosis requires activation of the caspase 
cascade, and we show here that HCMV reduced caspase-3 activ-
ity at 6 and 18 h postinfection (Figure 1F). Moreover, inhibition 
of apoptosis occurred in a viral dose-dependent manner, as 
assessed by both morphology and flow cytometry (Figures 1G,H). 
Testing of a further HCMV strain, TB40/e, an endothelial-tropic 
strain of HCMV that infects most cell types (46), revealed an 
identical dose-dependent effect (Figure 1I).
Ultracentrifugation of the viral inoculum, to pellet and remove 
all infectious virus, removed the survival effect (Figure  2A), 
indicating that the virion itself, rather than substances present in 
the viral inoculum, was responsible for survival. Of note, HCMV-
induced neutrophil survival was evident even in the absence of 
viral lytic gene expression. Hence, there was no evidence to sup-
port robust IE gene transcription within the neutrophil as judged 
by RT-PCR (Figure 2B) and only minute quantities detected by 
RT-qPCR (Figure 2C). Consistent with a lack of transcription, no 
IE protein was present on staining for IE expression 24 h postin-
fection (Figure  2D). Of note, neutrophil survival was equally 
evident with UV-inactivated virus (Figures 2E,F), implying that a 
virion component and not a viral protein synthesized de novo was 
responsible for the pro-survival effect. Thereafter, UV-inactivated 
HCMV was used for most subsequent experiments.
hcMV-induced neutrophil survival does 
not require internalization and signals 
through erK and nF-κB
To investigate the mechanism by which neutrophil survival was 
mediated, we first set out to determine whether viral uptake was 
necessary to trigger survival signaling. While EM images taken 
30  minutes postinfection revealed that very occasional HCMV 
virions are present within intracellular vesicles (Figure 3A), sug-
gestive of phagocytic uptake, the majority of particles remained 
extracellular, and pretreatment of neutrophils with the phagocy-
tosis/endocytosis inhibitors cytochalasin D or latrunculin A had 
no impact on the survival phenotype (Figure 3B). These obser-
vations suggested that HCMV-mediated neutrophil survival was 
dependent on a cell surface binding and/or postentry event medi-
ated in the absence of viral gene expression. This was explored 
by inhibiting a number of receptors known to be activated by 
HCMV. Blockade of CD13 (Figure 3C) or EGF-R (Figure 3D), 
previously reported receptors for HCMV, did not reduce 
survival. The role of TLRs in neutrophil survival has been well 
documented (47), and HCMV has been shown to signal through 
TLR2 (48); however, no impact on survival was demonstrated 
with inhibition of TLR2 (Figure 3E). Furthermore, blockade of 
TLR4 signaling, another receptor known to be involved in viral 
detection and pro-survival signaling, again did not influence the 
pro-survival phenotype (Figure 3F). The inhibitors were shown 
to be effective in inhibition of TLR signaling by blocking IL-8 
release by neutrophils in response to stimulation with agonists 
for TLR2 and TL4 (data not shown), but the agonists of TLR2 
(Pam3CSK4) and TLR4 (LPS) themselves did not exert a pro-
survival effect on neutrophils, further excluding the involvement 
of TLR2 and TLR4 in HCMV-induced survival (Figures 3G,H). 
We isolated ultrapure neutrophils (purity >99%) to mitigate any 
indirect effect of HCMV on contaminating monocytes, of which 
low numbers are present in our routine neutrophil preparations. 
The release of survival factors from contaminating monocytes has 
previously been noted to drive RSV-induced neutrophil survival 
(49, 50); however, our survival phenotype was still present in 
ultrapure neutrophil preparations (Figure  3I). The lack of any 
neutrophil survival effect when using mock transfected prepara-
tions, which had been prepared in an otherwise identical man-
ner as the HCMV preparations, also excluded any inadvertent 
contaminant effect such as lipopolysaccharide.
Human cytomegalovirus activates a number of signaling path-
ways in both permissive and non-permissive cells, including the 
PI3K and ERK-MAPK pathways, identified previously as impor-
tant for HCMV-mediated cell survival (51, 52), and the NF-κB 
pathway (53). We have previously published data indicating 
the importance of the PI3-kinase, MAPK, and NF-κB signaling 
pathways in neutrophil survival following GM-CSF and TNFα 
stimulation (44). Therefore, we used previously optimized con-
centrations of inhibitors of these pathways to assess involvement 
in the HCMV-induced neutrophil survival phenotype. Inhibition 
of the PI3K pathway, along with the p38-MAPK and JNK-MAPK 
pathways, did not affect HCMV-induced survival (Figure 4A), 
despite western blot showing activation of the PI3K pathway 
(Figure  4B). However, inhibition of both NF-κB (Figure  4C) 
and the ERK1/2 pathway (Figure 4D) led to a partial reduction 
in the HCMV survival effect, which was completely abrogated on 
blockade of both signaling pathways (Figures 4C,D). Consistent 
with these findings, Western blot analyses showed that HCMV 
treatment of neutrophils induced rapid ERK phosphorylation 
and IκB degradation (Figure 4E). ERK1/2 and NF-κB signaling 
have been implicated in the regulatory control of the balance 
FigUre 1 | Human cytomegalovirus (HCMV) inhibits the rate of constitutive neutrophil apoptosis. (a) Morphological analysis of neutrophil apoptosis in uninfected 
control (Mock) and infected (HCMV strain Merlin) cells at 20 h postinfection, shown with GM-CSF-treated positive control (MOI 3, n = 9), with (B) representative 
photomicrographs of cells with apoptotic cells indicated by arrows (magnification ×1,000). (c) Flow cytometry analysis of neutrophil apoptosis in cells infected  
with Merlin, by annexin V binding at 20 h (MOI 3, n = 7), with (D) representative flow cytometry plots shown. (e) Scanning electron microscopy (EM) images of 
neutrophils infected with Merlin for 20 h versus control, with smooth apoptotic cells indicated by arrow (bar represents 20 µm). (F) Colorimetric assay for  
caspase-3-activity performed at 0, 6, and 18 h on Mock (−) or HCMV strain Merlin (+) infected cells (MOI 3, n = 3). (g) Neutrophils infected with Merlin at an  
MOI of 3, 1, or 0.3 were assayed for apoptosis by morphology (n = 5–6) and by (h) flow cytometry (n = 3–5) at 20 h. (i) Neutrophils infected with HCMV strain 
TB40/e at an MOI of 3, 1, or 0.3 were assayed for apoptosis by morphology at 20 h (n = 3–8). *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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between the pro-apoptotic protein Bax and the antiapoptotic 
protein MCL-1, the relative levels of which are crucial for the 
onset of constitutive neutrophil apoptosis (54), and Western 
blotting for these two proteins revealed stabilization of MCL-1 
in response to HCMV infection but no change in Bax expression 
levels (Figure 4F).
FigUre 2 | Human cytomegalovirus (HCMV) promotion of neutrophil survival is independent of viral gene expression. (a) HCMV Merlin inoculum was 
ultracentrifuged at 180,000 g for 2 h, and the supernatant was removed from the virion pellet and used to infect neutrophils (virion-free inoculum). Apoptosis was 
assessed at 20 h by morphology (n = 3) compared to mock-infected cells and cells infected with non-centrifuged Merlin inoculum (Merlin). (B) RNA or DNA was 
isolated from neutrophils and RNA from human foreskin fibroblasts (HFFs) 18 h after infection with HCMV strain Merlin, and RNA was subjected to reverse 
transcription, and all samples were then amplified in an IE72 PCR or GAPDH PCR control before loading onto the gel. (c) qPCR showing gene expression levels  
of IE72 RNA isolated at 6 h from neutrophils infected with Merlin versus control, relative to Merlin-infected fibroblasts (MOI 3, n = 3). (D) Neutrophils were mock 
infected or incubated with HCMV for 24 h and then stained for immediate early (IE) antigen, shown with Hoescht nuclear counter stain and Merlin-infected HFFs  
as a positive control. (e) Morphological (n = 6) and (F) flow cytometric analysis (n = 5) of neutrophil apoptosis in cells infected with Mock or UV-inactivated Merlin  
at 20 h (MOI 3). Data represent mean ± SE, **p < 0.01, ***p < 0.001.
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hcMV-induced neutrophil survival  
is Viral strain specific
The pro-survival effect of HCMV on neutrophils was considered 
surprising, given the inability of HCMV to replicate efficiently 
inside the neutrophil. As such, the clinical relevance of this find-
ing was unclear, i.e., whether this represents an antipathogenic 
mechanism employed by the neutrophil or a form of immune 
subversion by the virus. The fact that clinical strains of the virus 
retain the evolutionarily conserved chemokine vCXC-1, a potent 
IL-8 homolog and neutrophil chemoattractant, suggested that 
recruitment of this cell type may be beneficial to the virus in the 
host setting.
To investigate this, neutrophils were co-incubated with 
the attenuated HCMV strain AD169, which has lost many of 
the genes carried in virulent isolates, including vCXC-1; this 
has been achieved through extensive passage resulting in the 
loss of multiple genes including the entire UL/b′ gene region 
encompassing UL133-UL151 (Figure  5A) (55). Rather strik-
ingly, neutrophils incubated with AD169 showed no survival 
phenotype (Figures 5B,C), strongly suggesting that a viral locus 
FigUre 3 | Human cytomegalovirus (HCMV)-stimulated neutrophil survival does not require internalization and does not signal through known receptors for 
HCMV. (a) Detection of viral particles (arrows) by transmission electron microscopy both outside and (inset) within HCMV strain Merlin-infected neutrophils 30 min 
postinfection (bar represents 500 nm). (B) Cytochalasin D or latrunculin A (10 µM) pretreatment did not influence neutrophil apoptosis following infection, 
compared with vehicle control (MOI 3, n = 3). (c) Morphological analysis of neutrophil apoptosis at 18 h in cells preincubated with the receptor tyrosine kinase 
inhibitor 324841 prior to Mock or Merlin infection (MOI 3, n = 3). (D) Morphological analysis of neutrophil apoptosis at 18 h in neutrophils pretreated with the CD13 
inhibitors actinonin or anti-CD13 clone WM15 before Mock or Merlin infection (MOI 3, n = 3). Neutrophils were incubated with inhibitors of (e) TLR2 (n = 3) or  
(F) TLR4 (n = 3) prior to infection with Merlin (MOI 3), and apoptosis was assessed by morphology at 20 h. Dose–response curves are shown measuring 
neutrophil apoptosis at 20 h by cell morphology and flow cytometry using annexin V for (g) the TLR2 agonist Pam3CSK4 (n = 1) and (h) the TLR4 agonist LPS 
(n = 1). (i) Morphological analysis of neutrophil apoptosis in mock and Merlin-infected ultrapure neutrophils at 20 h (MOI 1, n = 3). Data represent mean ± SE, 
*p < 0.05. NS, not significant.
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within the ULb′ region or another gene mutated in this strain 
was responsible for the survival effect. Of these, nine genes are 
probable virion components (P Tomasec, personal correspond-
ence), including UL146, a particularly strong candidate as it has 
been demonstrated to induce survival in human neutrophils 
(56), and UL141, which binds and downregulates the TRAIL 
death receptor on HFFs protecting them from extrinsic apop-
tosis (57).
To investigate the viral gene product responsible for HCMV-
induced neutrophil survival, we screened a library of Merlin 
strains each containing a single-gene knockout covering the 
entire 19 gene ULb′ region. Surprisingly, all of these mutants 
induced neutrophil survival comparable to wild-type Merlin, 
including all nine genes thought to code for virion components 
(Figures 5D–G), indicating that the HCMV-induced neutrophil 
survival effect is not driven by a single ULb′ gene product. These 
data implicate either an additional gene mutated in AD169 out-
side the ULb′ region or a combinatorial effect of multiple gene 
products. One prominent candidate gene outside the ULb′ region 
is the UL131A locus, which is mutated in AD169 (58, 59), and 
in Merlin is involved in the formation of the viral pentameric 
complex required for HCMV entry into myeloid lineage and epi-
thelial cells (60). However, when tested in isolation, the UL131A 
mutant also generated an intact survival response in neutrophils 
FigUre 4 | Human cytomegalovirus (HCMV)-induced neutrophil survival signals through multiple pathways. (a) Neutrophils were preincubated with the PI3K 
inhibitors LY294002 or wortmannin, the p38-MAPK inhibitor SB203580 or the JNK inhibitor SP600125 prior to infection with Merlin, and apoptosis was assessed by 
morphology at 20 h (MOI 3, n = 3–5). (B) Western blot analysis for total and phosphorylated AKT in neutrophils incubated with mock or HCMV at 5, 10, 15, and 
20 min (MOI 3). (c) Neutrophils were preincubated with the NF-κB inhibitors IKK inhibitor VII or BAY-11-7085 (3 or 10 µM), with or without addition of the ERK1/2 
inhibitor U0126, prior to HCMV infection, and apoptosis was assessed by flow cytometry using annexin V at 20 h (MOI 3, n = 2–4). (D) Neutrophils were 
preincubated with the ERK1/2 inhibitors PD98059 or U0126 (1, 10, or 20 µM), with or without the addition of BAY-11-7085, prior to infection with HCMV, and 
apoptosis was assessed by flow cytometry using annexin V at 20 h (MOI 3, n = 2–4). (e) Western blot analysis for ERK1/2 phosphorylation or IκB degradation was 
performed on mock or Merlin-infected neutrophils at 0, 5, 10, 15, 20, 30, and 40 min postinfection (MOI 3). (F) Western blot analysis for MCL-1 and Bax expression 
performed at 0 or 6 h after infection with mock or HCMV (MOI 3). Data represent mean ± SE, *p < 0.05, **p < 0.01, and ***p < 0.001.
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(Figures  5H,I), suggesting that the pentameric complex is not 
required for the survival phenotype.
hcMV infection induces a cellular 
secretome that Further Potentiates 
neutrophil survival
Since events associated with HCMV binding and entry are by 
definition transient, we then considered whether a positive 
feedback loop might also operate to prolong neutrophil survival, 
hypothesizing that any secretome produced by the neutrophils 
in response to HCMV may propagate the survival phenotype. 
Consistent with this, virus-free supernatants derived from 
neutrophils exposed to the Merlin strain imparted a profound 
antiapoptotic effect when transferred to freshly isolated neu-
trophils (Figures  6A,B). Of note, supernatants prepared in an 
otherwise identical manner from HCMV-infected monocytes 
did not promote neutrophil survival (Figure 6C). Furthermore, 
FigUre 5 | Human cytomegalovirus (HCMV)-induced neutrophil survival is viral strain specific. (a) The ULb′ region of the HCMV genome containing viral genes 
UL133–UL151 is lost in AD169 and replaced with inverted repeat RL14-1. (B) Neutrophils were incubated with the laboratory-adapted HCMV strain AD169 for 20 h, 
and apoptosis was assessed by cell morphology and (c) flow cytometry, compared to mock-infected neutrophils or neutrophils incubated with the clinical HCMV 
strain Merlin (MOI 3, n = 3–4). Neutrophils were incubated with wild-type Merlin or mutant Merlin strains lacking one of three genes from the ULb′ region of the 
HCMV genome known to code for virion components, and apoptosis was assessed at 20 h by (D) morphology and (e) flow cytometry (MOI 3, n = 3–4). Neutrophils 
were incubated with mutant strains lacking one of five ULb′ genes potentially coding for virion components, and apoptosis was assessed at 20 h by (F) morphology 
and (g) flow cytometry (MOI 3, n = 3). Neutrophils were incubated with wild-type Merlin versus Merlin lacking the UL131A gene, and apoptosis was assessed at 
20 h by (h) morphology and (i) flow cytometry (MOI 3, n = 3). Data represent mean ± SE. **p < 0.01, ***p < 0.001, and ****p < 0.0001. NS, not significant.
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supernatants from AD169-infected neutrophils did not convey a 
survival effect (Figure 6D), implying that this effect was restricted 
to clinical HCMV strains. The transferrable survival effect was 
not due to carryover of virus, as ultracentrifugation of superna-
tants to remove all virions (Figure 6E) caused no reduction in 
the survival conferred by the supernatant (Figure 6F), supporting 
instead a neutrophil-derived secreted factor.
As the HCMV secretome appeared to elicit downstream 
effects that were acting in a paracrine manner, we consequently 
performed a MesoScale™ cytokine array on supernatants from 
mock and HCMV-treated neutrophils to try to identify potential 
pro-survival agents from a panel of cytokines (Figure 7A). Initial 
analysis revealed significant increases in the concentrations of the 
known pro-survival cytokines TNFα, IL-6, and IL-8 along with 
the chemokine MIP-1α and the immune-regulatory cytokines 
IL-13 and IL-10 (Figure  7B), together with decreased levels 
of the chemotactic molecules IL-16 and MDC (Figure  7C). 
There was no upregulation of other potential survival cytokines 
including GM-CSF, IL-1β, IL-2, IL-4, IFNγ, IL-12p70, and VEGF 
(data not shown), and the only cytokine significantly higher in 
FigUre 6 | Human cytomegalovirus (HCMV)-exposed neutrophils produce a pro-survival secretome. Freshly isolated neutrophils were cultured with control media 
or supernatants from mock or Merlin-infected neutrophils (Merlin SN) collected at 20 h, and apoptosis was determined by (a) morphology and (B) flow cytometry at 
20 h (MOI 3, n = 3). (c) Supernatant from mock or Merlin-infected monocytes was added to freshly isolated neutrophils and apoptosis determined by morphology 
at 18 h (MOI 3, n = 3). (D) Supernatant from mock or AD169-infected neutrophils was added to freshly isolated neutrophils and apoptosis determined by 
morphology at 18 h (MOI 3, n = 3). (e) Supernatant harvested from mock and HCMV-infected neutrophils at 20 h was centrifuged at 130,000 g for 2 h, and residual 
virus in the ultracentrifuged pellet and supernatant (UC HCMV SN) was assessed by transferring to fibroblasts for 24 h prior to staining for HCMV immediate early 
(IE) antigen, compared to mock SN and non-ultracentrifuged HCMV supernatant (HCMV SN) (representative image shown). (F) The ultracentrifuged supernatant 
was transferred to fresh neutrophils and survival assessed by morphology at 20 h compared to non-ultracentrifuged supernatant (n = 4–5, MOI 3). Data represent 
mean ± SE. *p < 0.05, **p < 0.01, ***p < 0.001.
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Merlin-infected neutrophil supernatants compared to AD169 
supernatants was IL-10 (Figure 7B). HCMV has been shown to 
stimulate IL-10 production in monocytes (61), but rather than 
being pro-survival IL-10 has been shown to induce apoptosis in 
neutrophils (62). Consistent with this, we were unable to detect 
any survival effect of recombinant human IL-10 on human neu-
trophils (data not shown).
We investigated IL-8, a recognized pro-survival cytokine, 
which was secreted in high concentrations in HCMV-exposed 
neutrophils as measured by MesoScale array and confirmed by 
ELISA (Figure 7D) and which showed a trend to increased expres-
sion in Merlin supernatants over AD169 supernatants. However, 
although IL-8 has been shown to cause a modest inhibition of 
neutrophil apoptosis (63, 64), we were unable to recapitulate this 
effect in our system using recombinant human IL-8 (data not 
shown), and crucially, antibody depletion of the endogenous IL-8 
in the protective secretome using protein A beads (Figure 7E) 
had no effect on the transferrable survival (Figure 7F), indicating 
that IL-8 was not contributing to the survival effect observed.
interaction of hcMV with neutrophils 
Promotes a Permissive and immune-
suppressive Phenotype in Migrating 
Monocytes
Throughout these studies, the paradox between HCMV encoding 
a neutrophil chemoattractant and triggering marked neutrophil 
survival and heightened effector functions of neutrophils (32), 
and the minimal evidence that these cells represent a major site of 
productive infection or dissemination remains intriguing. While 
this could represent a host antiviral strategy, we speculated that 
the HCMV-induced neutrophil secretome may have a beneficial 
impact on the subsequent infection or activity of other cell types 
important for HCMV pathogenesis and dissemination. We set 
out to ascertain the effects of the neutrophil secretome on other 
immune cell types, predominantly the monocyte which plays 
a key role in HCMV dissemination and pathogenesis, to better 
understand the biological significance of HCMV prolonging 
neutrophil survival.
FigUre 7 | The human cytomegalovirus (HCMV)-exposed neutrophil secretome is high in IL-8. (a) MesoScale assay plate with three representative images, with 
each spot from three 10-plex wells representing one cytokine. The surrounding rings are imaging artifacts. (B) Results from MesoScale assay of mock and 
HCMV-infected (strain Merlin and AD169) neutrophil supernatants identified significant upregulation of IL-8, IL-6, TNFα, MIP-1α, IL-13, and IL-10 and downregulation 
of (c) MDC and IL-16 (MOI 3, n = 5). (D) IL-8 levels were measured in supernatants from mock- or HCMV-infected neutrophils at 20 h by ELISA (MOI 3, n = 5).  
(e) Following incubation with neutralizing antibodies against IL-8, supernatants were added to neutrophils and (F) apoptosis by morphology determined at 20 h, 
shown relative to control cells (MOI 3, n = 2–4). Data represent mean ± SE. *p < 0.05, **p < 0.01.
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The elevated levels of the chemokine MIP-1α in the secretome 
(Figure  7B) suggested the potential for increase in monocyte 
migration. A transwell migration assay confirmed this to be the 
case (Figure 8A). The ability of neutrophils to enhance monocyte 
recruitment is a classical response to pathogen invasion; however, 
in this instance, migration of monocytes occurred together with 
transformation of the monocytes to a cell status permissive for 
HCMV infection, which is comparable to classical DCs gener-
ated in vitro (Figures 8B,C). This monocyte switch to a HCMV-
permissive phenotype was dependent on the high levels of IL-6 
in the secretome (Figure 7B), as demonstrated by a substantial 
reduction in this effect in the presence of a neutralizing IL-6 
antibody (Figure 8D). IL-6 can be produced by monocytes and 
contaminating cells, so to eliminate the possibility that the IL-6 
was a product of contaminating monocytes, or already present 
in the viral inoculum generated from HFF supernatants, an IL-6 
ELISA was carried out on viral inoculum and on supernatants 
harvested from ultrapure neutrophil preparations infected with 
HCMV. IL-6 was not present in viral inoculum but was found 
in the ultrapure neutrophil supernatants, indicating that it is 
released from the neutrophils upon infection (Figure 8E).
The differential levels of IL-10 in our Merlin and AD169 
supernatants, although not responsible for survival, also led us 
to investigate its effect on monocyte immune function. IL-10 has 
been shown to polarize monocytes to an anti-inflammatory M2 
phenotype, with reduced MHC class II expression and decreased 
ability of monocytes to activate CD4+ T cells (65, 66). Consistent 
with this, our monocytes cultured in HCMV-exposed neutrophil 
supernatants failed to stimulate T cell division in a mixed leukocyte 
reaction (Figure 8F) and showed strong downregulation of MHC 
class II (Figure 8G). Thus, HCMV interaction with neutrophils 
was shown to promote the secretion of a cytokine profile that is 
chemotactic for monocytes and drives their subsequent activa-
tion to a HCMV-permissive and immune-suppressive phenotype.
DiscUssiOn
The precise nature of the interaction of HCMV with neutro-
phils has been challenging to resolve. Although HCMV has been 
reported to heightened certain neutrophil effector functions (32) 
and HCMV can transfer to neutrophils following co-culture with 
permissive cells through microfusion events (31), the ability of 
neutrophils to support full lytic viral replication has never been 
shown conclusively, with viral cycling restricted to early replica-
tion events only (31, 32). The reason for this block in replication 
is not known. Although the detection of viral antigens has been 
identified in the neutrophils of viremic patients (25), this is 
likely to represent non-specific phagocytosis, because in healthy 
FigUre 8 | Supernatants from human cytomegalovirus (HCMV)-exposed neutrophils promote monocyte migration and activation to a permissive phenotype in an 
IL-6-dependent manner. (a) Monocytes were cultured in transwell plates in the presence of control media, or media from mock- or HCMV-infected neutrophils, or 
from LPS-activated monocytes as a positive control, and migration assessed by microscopy after 2 h (n = 3). (B) Autologous donor monocytes were cultured in 
control media, mock-infected neutrophil media, or Merlin-infected neutrophil media, and freshly infected with Merlin, alongside IL-4/GM-CSF-induced dendritic cells 
(DCs) as a positive control. Cells were stained for immediate early (IE) gene expression at 24 h and counterstained with Hoechst nuclear dye, and (c) relative levels 
of infection calculated from 10 fields of view (MOI 3, n = 3). (D) Neutralization of IL-6 in supernatant from mock or Merlin-infected neutrophils significantly inhibited 
the number of monocytes positive for IE gene expression (n = 3). (e) IL-6 levels by ELISA in viral inoculum and in mock-infected and Merlin-infected ultrapure 
neutrophils (purity >99%) (n = 2). (F) Monocytes were incubated with media (monocyte) or supernatants from mock- or Merlin-infected neutrophils for 3 days.  
Media was then removed, and allogeneic CD4+ T cells were added to each well along with phytohemagglutinin (PHA) to all conditions except control. T cell 
proliferation after 6 days of co-culture was assessed by counting and shown relative to T cells cultured alone (control) or in the presence of PHA alone (PHA)  
(n = 2). (g) Representative flow cytometry plots of autologous monocytes cultured in X-vivo-15 media (control), mock-infected neutrophil media, or HCMV-infected 
neutrophil media (MOI 3) for 3 days before staining for MHC class I and II. Data represent mean ± SE. *p < 0.05.
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seropositive individuals, neutrophils do not appear to be a site 
of viral carriage (24). As such, the precise benefit of HCMV 
retaining vCXC-1 or why HCMV-infected permissive cell lines 
secrete the chemokines IL-8 and CXCL-1 and induce neutrophil 
chemotaxis (67, 68) is uncertain.
In this study, we sought to understand the nature of the 
interaction between HCMV and neutrophils at a cellular level, 
to elucidate the mechanisms involved in the neutrophil survival 
we observed, and to determine potential downstream effects 
of the virus–cell interaction on neighboring neutrophils and 
monocytes, to determine the potential significance of our find-
ings in  vivo. Herein, we show for the first time a pronounced 
effect of cell-free clinical HCMV isolates on the biology of this 
cell, an effect that is preserved in UV-treated virus but absent in 
an attenuated HCMV strain. We describe how the interaction of 
HCMV with neutrophils triggers a profound survival phenotype 
that involves ERK phosphorylation and IκB degradation and 
correlates with MCL-1 stabilization, along with the secretion of 
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a bioactive secretome that promotes further neutrophil survival, 
monocyte chemotaxis, and development of monocyte permis-
siveness for HCMV infection.
Previous studies have reported that co-culture with HCMV-
infected endothelial cells or fibroblasts protects neutrophils from 
apoptosis, at least in part due to IL-8 secreted by the co-cultured 
cells (32, 33). Skarman et al. described a co-culture system of neu-
trophils with HCMV-infected endothelial cells, in which the neu-
trophils showed reduced apoptosis (32); the authors concluded 
that neutrophil survival was linked to lytic gene expression due to 
the detection of IE antigen. In those experiments, neutrophils did 
not become positive for the main viral antigen pp65 when incu-
bated with cell-free virus; hence, no investigation of neutrophil 
survival with cell-free virus was made. Furthermore, the study 
referred to endothelial cells infected with laboratory HCMV 
strains, which were then co-cultured with neutrophils; however, 
here, we report that direct inoculation of neutrophils with wild-
type strains of HCMV promotes survival and demonstrate that 
the lab strain used in the previous study does not promote survival 
directly. A further study has also shown that, when co-cultured 
with HCMV-infected endothelial cells or fibroblasts, neutrophils 
display a reduction in apoptosis (33). Indeed, that study reported 
that the neutrophils also showed reduced apoptosis when co-
cultured with non-infected endothelial cells and demonstrated 
that the survival was due to IL-8 produced by both infected and 
non-infected endothelial cells. Hence, the Skarman study failed 
to disentangle the effects of a secretome generated from a virally 
infected bystander cell from direct engagement of the neutrophil 
with cell-free HCMV.
The inhibition of neutrophil apoptosis may be significant in 
multiple ways for the host, as it has the potential to exacerbate 
tissue damage but also to aid viral clearance. Neutrophil influx 
to sites of viral infection is associated with inflammation and 
tissue damage in influenza (69) and RSV (70). It is suggested 
that increased neutrophil viability may lead to greater HCMV-
induced tissue damage in PCR-positive inflammatory bowel 
disease (32, 71), and the observation that neutrophil survival is 
absent with the attenuated HCMV strain AD169 would support 
the hypothesis that it is a virulence mechanism.
Conversely, in murine CMV infection, neutrophils form a 
critical part of the antiviral response and are shown to play a 
direct role in controlling viral replication and limiting morbidity 
(17), a role also seen in RSV (72), HSV (15), and HIV infection 
(73). Interestingly, neutrophils support viral replication in West 
Nile virus infection and are actively recruited during infection, 
acting as a reservoir for replication, and only become involved in 
viral clearance at a later stage (74). The presence of vCXC-1 and 
other chemokines would support a similar role in HCMV.
The potential benefit to the virus of a reduction in neutrophil 
apoptosis may be multifaceted. Prolonged neutrophil survival 
can delay the adaptive immune response, through a reduc-
tion in formation of apoptotic vesicles that would otherwise be 
ingested by monocytes or DCs and trafficked to lymph nodes 
for antigen presentation, as occurs in Mycobacterium tuberculosis 
(12). In addition, despite limited viral replication in neutrophils, 
there is evidence that the neutrophil may be used by the virus 
for dissemination. Circulating HCMV-infected neutrophils may 
act as a “Trojan horse” to infect other cell types, as neutrophils 
infected by co-culture are seen to transmit to naive permissive 
cells via cell-to-cell transfer of viral particles, even up to 48  h 
after initial separation (33). HCMV infection often results in a 
concerted antiapoptotic response to prolong host cell lifespan 
for replication, and during lytic infection, the virus encodes an 
array of antiapoptotic proteins that target caspase-8 (UL36) (75), 
mitochondrial membrane stability (UL37 ×  1) (76), ER stress 
(UL38) (77), ATP production (b2.7) (78), and p53 (IE2) (79). 
The survival effect we observe in neutrophils, involving a likely 
virion–cell surface interaction, is similar to that observed during 
non-permissive infection of CD14+ and CD34+ cells (51, 52), 
where ERK and PI3K signaling were shown to be key. In that 
study, HCMV glycoprotein B was an important agonist of the 
survival response in CD34+ cells, yet this seems unlikely to be 
the case here since AD169 is not protective. It is possible that the 
model proposed for the survival of monocytes, which requires 
multiple signaling events, could be relevant in the neutrophil (80).
Furthermore, the cytokine profile we see here released by the 
longer-lived HCMV-exposed neutrophils appears to provide a 
further advantage to the virus through further potentiation of 
neutrophil survival and through effects on circulating monocytes, 
through recruitment, differentiation, and activation to render 
these cells permissive for HCMV. We were unable to identify the 
survival factor(s) present in the secretome, as our screen of 29 
cytokines did not highlight any prosurvival factors upregulated 
in Merlin supernatants and an array of 39 more growth factors 
and soluble receptors failed to identify any other significantly 
upregulated factors (data not shown). However, we were able 
to pinpoint IL-6 as a contributor to monocyte permissivity. The 
reactivation of HCMV has been previously reported from mono-
cytes activated by cytokine stimulation including IL-6 (81), 
suggesting that limited monocyte differentiation/activation may 
be sufficient to trigger a permissive phenotype, which is consist-
ent with our data. However, acute treatment with recombinant 
IL-6 has not been shown to induce monocyte permissiveness for 
HCMV infection alone (82), implying that either the effects of 
IL-6 are chronic long-term effects or, in fact, may be working in 
concert with other factors. A likely candidate is IL-13, which we 
observed the upregulation of in our secretome analyses. IL-13 
is a member of the IL-4 cytokine family and has been shown to 
support monocyte differentiation (83)—a hypothesis consistent 
with the knowledge that differentiation is a key determinant of 
myeloid cell permissiveness for HCMV infection (84).
In the context of a HCMV infection in vivo, the induction of 
a pro-survival secretome is highly suggestive of a host antiviral 
response, so this appears to represent an antiviral strategy of unex-
pected benefit to HCMV. Neutrophils are among the first cells to 
traffic to the site of primary HCMV infection, with cross-cellular 
communications a crucial component of the initial response. This 
in turn leads to monocyte recruitment, to promote clearance of 
apoptotic debris generated by the initial neutrophil response, 
which here would facilitate enhanced dissemination of HCMV, a 
process in which monocytes are argued to be key (85, 86).
The absence of the phenotype with the non-virulent strain 
AD169 implies that the survival effect is due to a virulence gene, 
non-essential for growth, which has been lost or mutated in 
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AD169 through extensive passage. Unfortunately, our screen of 
ULb′ knockouts did not identify any single gene to be responsi-
ble, and AD169 carries many other mutations besides the ULb′ 
deletion that could be responsible. We included a Merlin mutant 
lacking UL131A, which lies just outside the ULb′ region and is 
essential for the formation of the intact gH-gL-UL128-UL130-
UL131A pentameric complex, required for leukocyte tropism and 
entry; although UL131A carries a truncation mutation in AD169 
and would seem a likely candidate, once again no change to the 
phenotype was seen. Repeated attempts to generate a knockout of 
the whole ULb′ region against a Merlin backbone have not been 
successful to date, but if available in the future, such a mutant 
would help to address the question of whether the survival effect 
is due to a combinatorial effect of ULb′ genes, or another gene 
mutated in AD169 and present in the virion. HCMV contains 
at least 59 structural proteins (87), including the antiapoptotic 
UL38, and some of these carry mutations in AD169, including 
the membrane glycoprotein O (UL74) that forms the gH-gL-gO 
entry complex (88, 89). Of particular interest are UL36, an inhibi-
tor of caspase-induced apoptosis (75), its antiapoptotic intronic 
micro-RNA mir-UL36-5p (90), and the pro-survival non-coding 
RNA b2.7 (78). All three are present in or carried on the virion 
(91, 92), carry at least minor mutations in AD169 (88, 89, 91), 
and are targets for further investigation.
In summary, we have demonstrated for the first time that 
the HCMV virion has a profound effect on neutrophil biology, 
delaying apoptosis and inducing the release of a highly bioactive 
secretome with the capacity to propagate neutrophil survival and 
to induce monocyte chemotaxis and differentiation to a permis-
sive, anti-inflammatory phenotype. In the context of clinical 
infection, this is likely to represent a host response that provides 
an unexpected benefit to the virus, and although significant 
resolution of infection is likely to occur, differentiating mono-
cytes provide the ideal vehicle for viral dissemination and the 
establishment of a lifelong persistent infection. A persistent infec-
tion without pathology in the host would, in evolutionary terms, 
represent an ideal scenario for the virus. This report highlights 
how the interaction of a viral pathogen with a cell type not capa-
ble of supporting lytic infection can still have a pronounced effect 
on both the biology of that cell and the wider immune response.
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